Key Segmentation:
By Product Type
-
Intermittent Catheters
-
Indwelling Catheters
-
External Catheters
By Coating
-
Coated Catheters
-
Uncoated Catheters
By Application
-
Urinary Incontinence
-
Benign Prostatic Hyperplasia
-
Spinal Cord Injury
-
Post-Surgical Urinary Retention
-
Other Applications
By End User
-
Hospitals
-
Home Care
-
Long-Term Care Facilities
-
Clinics
By Gender
-
Male
-
Female
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Coloplast, Hollister, Convatec, Wellspect HealthCare (Dentsply Sirona), BD (C.R. Bard), Teleflex, B. Braun, Cardinal Health, Medline, Poiesis Medical, HR Healthcare, Poly Medicure, Well Lead Medical, Guangdong Ecan Medical, Hangzhou Jimushi Meditech, Chengdu Daxan Innovative Medical Technology and Amsino International.
Key opportunities include female external catheters, antimicrobial and ready-to-use coated catheters, smart infection-detecting catheters and home care supply services in emerging markets.
Population aging, rising prostate disease and incontinence, and the shift of catheter care to the home are the main growth factors.
By Product Type, the Intermittent Catheters segment dominated the market in 2025 with an estimated 57.82% share, supported by clinical guidelines that favor single-use catheterization.
North America dominated the market with a share of 38.28% in 2025, driven by high disease prevalence, broad insurance coverage and early adoption of advanced catheters.